Key result
Medical thromboprophylaxis studies in patients with cancer have excluded individuals with advanced disease and short life expectancy.
Why the study?
Does medical thromboprophylaxis with anticoagulants prevent venous thromboembolism in patients with cancer in palliative care?
Does medical thromboprophylaxis with anticoagulants prevent venous thromboembolism in patients with cancer in palliative care?
Highlights the lack of evidence for thromboprophylaxis in patients with advanced cancer and short life expectancy.
Cancer is an important risk factor for venous thromboembolism, and patients with cancer are therefore good candidates for medical thromboprophylaxis with anticoagulants. Many studies on thromboprophylaxis that include patients with cancer have been done, but these studies excluded patients with advanced cancer and short life expectancy.1
No takes yet. Share an insight, caveat, or question.
Sandset et al. (2019) studied this question. Medical thromboprophylaxis studies in patients with cancer have excluded individuals with advanced disease and short life expectancy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: